- as per
Aggregated return during this time range :
The LUX-PORTFOLIO GLOBAL FLEXIBLE SERENITY subfund invests its assets in bonds who benefits from an "Investment Grade" rating and up to 50% in high-capitalization equities, listed on the major stock exchanges, particularly in OECD countries. The LUX-PORTFOLIO GLOBAL FLEXIBLE SERENITY subfund promotes a flexible weighting of the different asset classes (equities, bonds, money market instruments) with an investment level in equities of up to 50%.
This subfund is eligible for S-Invest, the strategy for investing in LUXFUNDS sicavs.
|for 1 month (03/06/2022)||-0.75%|
|for 3 months (05/04/2022)||-5.52%|
|for 6 months (05/01/2022)||-11.44%|
|for 1 year (05/07/2021)||-9.66%|
|for 3 years (05/07/2019)||-5.70%|
|for 5 years (05/07/2017)||0.48%|
|as from creation (19/12/2016)||-1.48%|
Investment allocation as per 30/06/2022
Exposure as per 31/03/2022
Geographical breakdown of the equity investments as per 30/06/2022
Top equity investments as per 30/06/2022
|Apple Inc Reg||1.10 %|
|Microsoft Corp||0.82 %|
|Mastercard Inc A||0.53 %|
|LVMH Moët Hennessy L Vuit SE||0.50 %|
|United Health Group Inc||0.50 %|
Top bond investments as per 30/06/2022
|Finland 4% 09/04.07.25||5.14 %|
|Deutschland 4.75% Ser 98 98/04.07.28||4.04 %|
|Oesterreich 1.75% 13/20.10.23||3.86 %|
|France 0.5% OAT Sen 14/25.05.25||3.84 %|
|Belgium 0.8% OLO Reg S Ser 74 15/22.06.25||3.54 %|
|Investment fund types||Mixed Funds|
|Type of shares||cap.|
|LU Withholding tax||No|
|Calculation of the net asset value||Daily|
|For every subscription today (day D) before noon (Luxembourg time), the NAV applicable will be the NAV dated today (D), which will be calculated and published the next day (day D+1), except for Sundays and holidays.|
|ISIN code (cap.)||LU1527456997|
|Cut-off time||12:00 (GMT+1)|
|Entry charges||2.50 %|
|Exit charges||1.00 %|
|Charges taken from the fund over a year|
|Ongoing charges||CAP 1.40 %|
|Charges taken from the fund under certain specific conditions|
Detailed Informations about the fees and charges are in our publication concerning the main banking fees available at www.spuerkeess.lu and in our branches.
AS AT 05/07/2022
|TIS belge||-10.30 EUR|
Please note that the above subfund may only be distributed in Luxembourg. Shares of funds of our lux|funds range may not be sold to US Persons.
Any subscription must be done on the basis of the fund's prospectus in effect at the time of subscription and the KIID ("Key Investor Information Document"), accompanied by the latest annual report or, if more recent, the latest interim report.
For every subscription today (day D) before noon (Luxembourg time), the NAV applicable will be the NAV dated today (D), which will be calculated and published the next day (day D+1), except for Sundays and holidays.
The indicated historical performance levels are not a guarantee of similar growth in value in the future. Losses of value cannot be ruled out, and Spuerkeess may not be held liable for them. The actuarial yield represents the yield obtained when a bond portfolio is held to maturity.
The level of risk is determined on the basis of the historical performance of the last five years and should not be considered a reliable indicator of the future risk profile of the compartment. It represents the risk of fluctuations in the net asset value per share and may change over time. Level 1 represents the lowest risk, and level 7 represents the highest risk. The higher the risk, the longer the recommended investment period. For details on the risks involved, please consult the KIID.
The entry and exit charges are those indicated in the prospectus. The actual applicable charges are in our publication concerning the main banking fees available at www.spuerkeess.lu and in our branches.
Tax information about the fund is available at www.luxfunds.lu and at Spuerkeess branches. It is recommended that investors consult their own legal and tax advisers before investing in the fund.
This document is provided solely for information purposes and cannot be considered legal, tax, or investment advice.